Sign in
Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells
Journal article   Open access  Peer reviewed

Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells

YUSHE DANG, Wolfgang M WAGNER, Ekram GAD, Lauren RASTETTER, Carmen M BERGER, Gregory E HOLT and Mary L DISIS
Clinical cancer research, Vol.18(11), pp.3122-3131
2012
PMID: 22510348

Abstract

Biological and medical sciences Medical sciences Antineoplastic agents Pharmacology. Drug treatments
url
https://doi.org/10.1158/1078-0432.CCR-12-0113View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.358 Dendritic Cells
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details